{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:09:37Z","timestamp":1777936177902,"version":"3.51.4"},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.2169\/internalmedicine.5918-25","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T22:08:29Z","timestamp":1759356509000},"page":"1190-1198","source":"Crossref","is-referenced-by-count":0,"title":["The Assessment of Interatrial Septum Thickness by Echocardiography in Wild-type Transthyretin Amyloidosis"],"prefix":"10.2169","volume":"65","author":[{"given":"Daigo","family":"Hirakawa","sequence":"first","affiliation":[{"name":"Heart Failure Center, Kochi Medical School Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juri","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation 126: 1286-1300, 2012.","DOI":"10.1161\/CIRCULATIONAHA.111.078915"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kitaoka H, Izumi C, Izumiya Y, et al.; the Japanese Circulation Society Joint Working Group. JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis. Circ J 84: 1610-1671, 2020.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120: 1203-1212, 2009.","DOI":"10.1161\/CIRCULATIONAHA.108.843334"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bay K, Gustafsson F, Maiborg M, et al. Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review. ESC Heart Fail 9: 1524-1541, 2022.","DOI":"10.1002\/ehf2.13884"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol 24: 343-350, 2015.","DOI":"10.1016\/j.carpath.2015.07.008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Okada A, Kakuta T, Tadokoro N, et al. Transthyretin derived amyloid deposits in the atrium and the aortic valve: insights from multimodality evaluations and mid-term follow up. BMC Cardiovasc Disord 23: 281, 2023.","DOI":"10.1186\/s12872-023-03319-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cuddy SAM, Chetrit M, Jankowski M, et al. Practical points for echocardiography in cardiac amyloidosis. J Am Soc Echocardiogr 35: A31-A40, 2022.","DOI":"10.1016\/j.echo.2022.06.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koyama J, Minamisawa M, Sekijima Y, Kuwahara K, Katsuyama T, Maruyama K. Role of echocardiography in assessing cardiac amyloidoses: a systematic review. J Echocardiogr 17: 64-75, 2019.","DOI":"10.1007\/s12574-019-00420-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Merlo M, Porcari A, Pagura L, et al. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study. Eur J Prev Cardiol 29: e173-e177, 2022.","DOI":"10.1093\/eurjpc\/zwab127"},{"key":"10","unstructured":"10. Merlo M, Pagura L, Porcari A, et al. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey. Eur J Heart Fail 24: 1377-1386, 2022."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Moody WE, Turvey-Haigh L, Knight D, et al. British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis. Echo Res Pract 10: 13, 2023.","DOI":"10.1186\/s44156-023-00028-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dorbala S, Ando Y, Bokhari S, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2 -Evidence Base and Standardized Methods of Imaging. Circ Cardiovasc Imaging 14: e000029, 2021.","DOI":"10.1161\/HCI.0000000000000029"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Siqueira-Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT, Giuliani ER. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 63: 188-196, 1981.","DOI":"10.1161\/01.CIR.63.1.188"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Falk RH, Plehn JF, Deering T, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 59: 418-422, 1987.","DOI":"10.1016\/0002-9149(87)90948-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32: 1-64, 2019.","DOI":"10.1016\/j.echo.2018.06.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Badano LP, Kolias TJ, Muraru D, et al.; Industry representatives. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19: 591-600, 2018.","DOI":"10.1093\/ehjci\/jey042"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gillmore JD, Damy T, Fontana M, et al. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39: 2799-2806, 2018.","DOI":"10.1093\/eurheartj\/ehx589"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Grogan M, Scott CG, Kyle RA, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol 68: 1014-1020, 2016.","DOI":"10.1016\/j.jacc.2016.06.033"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ishihara S, Hiramitsu S, Kanaoka K, et al. New conversion formula between B-type natriuretic peptide and N-terminal-pro-B-type natriuretic peptide - analysis from a multicenter study. Circ J 86: 2010-2018, 2022.","DOI":"10.1253\/circj.CJ-22-0032"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Liu D, Hu K, Niemann M, et al. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy. Circ Cardiovasc Imaging 6: 1066-1072, 2013.","DOI":"10.1161\/CIRCIMAGING.113.000683"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98: 1442-1448, 2012.","DOI":"10.1136\/heartjnl-2012-302353"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Silvestry FE, Cohen MS, Armsby LB, et al.; American Society of Echocardiography; Society for Cardiac Angiography and Interventions. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 28: 910-958, 2015.","DOI":"10.1016\/j.echo.2015.05.015"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cameli M, Lisi M, Righini FM, Mondillo S. Novel echocardiographic techniques to assess left atrial size, anatomy and function. Cardiovasc Ultrasound 10: 4, 2012.","DOI":"10.1186\/1476-7120-10-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sweeney LJ, Rosenquist GC. The normal anatomy of the atrial septum in the human heart. Am Heart J 98: 194-199, 1979.","DOI":"10.1016\/0002-8703(79)90221-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Agmon Y, Meissner I, Tajik AJ, et al. Clinical, laboratory, and transesophageal echocardiographic correlates of interatrial septal thickness: a population-based transesophageal echocardiographic study. J Am Soc Echocardiogr 18: 175-182, 2005.","DOI":"10.1016\/j.echo.2004.09.002"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Galzerano D, Tuccillo B, Lama D, Paolisso G, Mirra G, Giasi M. Morpho-functional assessment of interatrial septum: a transesophageal echocardiographic study. Int J Cardiol 5: 73-77, 1995.","DOI":"10.1016\/0167-5273(95)02403-J"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Qadir F, Ashraf T, Aamir KF, et al. Measurement of interatrial septal thickness by echocardiography in patients with moderate to severe rheumatic mitral stenosis undergoing percutaneous balloon mitral valvuloplasty. Int J Cardiol Heart Vasc 22: 35-38, 2018.","DOI":"10.1016\/j.ijcha.2018.11.007"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Elagha A, Othman Y, Darweesh R, Awadein G, Hashad A. Characterization of the interatrial septum by high-field cardiac MRI: a comparison with multi-slice computed tomography. Egypt Heart J 72: 81, 2020.","DOI":"10.1186\/s43044-020-00109-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Shah O, Choh N, Shera T, et al. Magnetic resonance imaging in cardiac amyloidosis: unraveling the stealth entity. Int J Angiol 31: 40-47, 2021.","DOI":"10.1055\/s-0041-1735948"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ichimata S, Hata Y, Hirono K, Yamaguchi Y, Nishida N. Clinicopathological features of clinically undiagnosed sporadic transthyretin cardiac amyloidosis: a forensic autopsy-based series. Amyloid 28: 125-133, 2021.","DOI":"10.1080\/13506129.2021.1882979"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. R\u00f6cken C, Peters B, Juenemann G, et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation 106: 2091-2097, 2002.","DOI":"10.1161\/01.CIR.0000034511.06350.DF"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fayyaz AU, Bois MC, Dasari S, et al. Amyloidosis in surgically resected atrial appendages: a study of 345 consecutive cases with clinical implications. Mod Pathol 33: 764-774, 2020.","DOI":"10.1038\/s41379-019-0407-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Larsen BT, Mereuta OM, Dasari S, et al. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases. Histopathology 68: 648-656, 2016.","DOI":"10.1111\/his.12793"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Okada A, Kakuta T, Tadokoro N, et al. Transthyretin derived amyloid deposits in the atrium and the aortic valve: insights from multimodality evaluations and mid-term follow up. BMC Cardiovasc Disord 23: 281, 2023.","DOI":"10.1186\/s12872-023-03319-3"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Di Bella G, Minutoli F. Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor. Amyloid 25: 135, 2018.","DOI":"10.1080\/13506129.2018.1450240"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Hussain M, Krywanczyk A, Donnellan E, et al. Association between atrial uptake on cardiac scintigraphy with technetium-99m-pyrophosphate labeled bone-seeking tracers and atrial fbrillation. Circ Cardiovasc Imaging 15: e013829, 2022.","DOI":"10.1161\/CIRCIMAGING.121.013829"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Fyke FE 3rd, Tajik AJ, Edwards WD, Seward JB. Diagnosis of lipomatous hypertrophy of the atrial septum by two-dimensional echocardiography. J Am Coll Cardiol 1: 1352-1357, 1983.","DOI":"10.1016\/S0735-1097(83)80151-X"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5918-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:21:59Z","timestamp":1777692119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_5918-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5918-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"5918-25"}}